Arch Biopartners Stock Price on June 27, 2023
| ARCH Stock | CAD 1.77 0.05 2.91% |
Below is the normalized historical share price chart for Arch Biopartners extending back to May 07, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arch Biopartners stands at 1.77, as last reported on the 23rd of December, with the highest price reaching 1.79 and the lowest price hitting 1.70 during the day.
If you're considering investing in Arch Stock, it is important to understand the factors that can impact its price. At this stage we consider Arch Stock to be risky. Arch Biopartners secures Sharpe Ratio (or Efficiency) of 0.0506, which signifies that the company had a 0.0506% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Arch Biopartners, which you can use to evaluate the volatility of the firm. Please confirm Arch Biopartners' mean deviation of 1.95, and Risk Adjusted Performance of 0.0465 to double-check if the risk estimate we provide is consistent with the expected return of 0.14%.
At this time, Arch Biopartners' Other Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 2.4 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (4.7 M). . Price To Sales Ratio is likely to drop to 1.78 in 2024. Price Earnings Ratio is likely to drop to -1.48 in 2024. Arch Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 1.7674 | 50 Day MA 1.8464 | Beta 1.39 |
Arch |
Sharpe Ratio = 0.0506
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | ARCH | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.68 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Arch Biopartners is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arch Biopartners by adding it to a well-diversified portfolio.
Enterprise Value Ebitda (97.59) | Price Sales 83.075 | Shares Float 49.8 M | Earnings Share (0.03) | Shares Short 4 K |
Arch Biopartners Valuation on June 27, 2023
It is possible to determine the worth of Arch Biopartners on a given historical date. On June 27, 2023 Arch was worth 2.16 at the beginning of the trading date compared to the closed value of 2.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arch Biopartners stock. Still, in general, we apply an absolute valuation method to find Arch Biopartners' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arch Biopartners where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arch Biopartners' related companies.
| Open | High | Low | Close | Volume | |
| 1.99 | 2.16 | 1.97 | 2.14 | 77,101 | |
06/27/2023 | 2.16 | 2.38 | 2.16 | 2.30 | 149,910 |
| 2.30 | 2.30 | 2.18 | 2.18 | 38,881 |
| Backtest Arch Biopartners | | | Arch Biopartners History | | | Arch Biopartners Valuation | Previous | Next |
Arch Biopartners Trading Date Momentum on June 27, 2023
| On June 28 2023 Arch Biopartners was traded for 2.18 at the closing time. The maximum traded price for the trading interval was 2.30 and the lowest daily price was 2.18 . The daily volume was recorded at 38.9 K. The volume of trading on 28th of June 2023 played a part in the next trading day price drop. The overall trading delta to the next closing price was 5.22% . The overall trading delta to the closing price today is 8.70% . |
Arch Biopartners Fundamentals Correlations and Trends
By evaluating Arch Biopartners' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arch Biopartners' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arch financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arch Biopartners Stock history
Arch Biopartners investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arch is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arch Biopartners will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arch Biopartners stock prices may prove useful in developing a viable investing in Arch Biopartners
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 71.8 M | 41.8 M | |
| Net Loss | -1.3 M | -1.3 M |
Arch Biopartners Stock Technical Analysis
Arch Biopartners technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arch Biopartners Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Arch Biopartners cannot be verified against its exchange. Please verify the symbol is currently traded on TSX Venture Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Arch Biopartners December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Arch Biopartners stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arch Biopartners shares will generate the highest return on investment. By undertsting and applying Arch Biopartners stock market strength indicators, traders can identify Arch Biopartners entry and exit signals to maximize returns
Arch Biopartners Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arch Biopartners' price direction in advance. Along with the technical and fundamental analysis of Arch Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arch to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0465 | |||
| Jensen Alpha | 0.1081 | |||
| Total Risk Alpha | 0.0477 | |||
| Sortino Ratio | 0.0363 | |||
| Treynor Ratio | 0.1979 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Arch Stock Analysis
When running Arch Biopartners' price analysis, check to measure Arch Biopartners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Biopartners is operating at the current time. Most of Arch Biopartners' value examination focuses on studying past and present price action to predict the probability of Arch Biopartners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Biopartners' price. Additionally, you may evaluate how the addition of Arch Biopartners to your portfolios can decrease your overall portfolio volatility.